Syros Pharmaceuticals, Inc. Syros Pharmaceuticals, Inc.

An Expression Makes a World of Difference

By creating medicines to control the expression of genes that have gone awry in disease, we aim to make a profound difference in the lives of patients and their families.

Our Message to Patients
Nancy Simonian, M.D.Chief Executive Officer

Our Message to Patients

At the heart of all our efforts at Syros is our dedication to advancing medicines that provide a profound and durable benefit for patients with difficult-to-treat diseases.

Read Our Message

Diseases We Target

We currently have two programs in clinical trials in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced solid tumors, including triple negative breast, small cell lung and ovarian cancers. We have additional programs in earlier stages of research for cancer, autoimmune diseases and genetic disorders.

Read More About the Diseases We Target
Our Clinical Trials
RobertMDS Patient

Our Clinical Trials

Interested in participating in a clinical trial?

Learn More About Our Clinical Trials